SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-004752
Filing Date
2020-01-09
Accepted
2020-01-09 16:46:03
Documents
4
Period of Report
2020-01-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d861964d8k.htm 8-K 28962
2 EX-10.1 d861964dex101.htm EX-10.1 67326
3 EX-10.2 d861964dex102.htm EX-10.2 257626
4 EX-99.1 d861964dex991.htm EX-99.1 10685
  Complete submission text file 0001193125-20-004752.txt   365800
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 20518606
SIC: 3841 Surgical & Medical Instruments & Apparatus